- ►nih.gov - Free from Publisher H Siatiri, AH Beheshtnezhad, H Asghari, N … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Methods: The study was done as a double masked randomised clinical trial between
April 2002 and November 2003 in Farabi Eye Hospital. 34 eyes of 26 patients with
congenital cataract were included in the study and randomised into two ... Cited by 7 - Related articles - BL Direct - All 9 versions
PA Gerding Jr, RE Hamor, DT Ramsey, S … - American journal of veterinary research, 1994 - ncbi.nlm.nih.gov Fibrin clots were induced in eyes of dogs by injection of autogenous citrated
plasma into the anterior chamber. Twenty-four hours after clot formation, one
50-microliters drop of tissue plasminogen activator at a concentration of 5 ... Cited by 4 - Related articles - BL Direct - All 3 versions
L Laatikainen, J Mattila - Graefe's Archive for Clinical and Experimental …, 1996 - Springer Abstract • Background: We want- ed to evaluate whether intracameral injection
of tissue plasminogen ac- tivator (tPA) is useful in managing traumatic
hyphaema. • Methods: Two eyes with total hyphaema after a severe ... Cited by 9 - Related articles - BL Direct - All 3 versions
A Wedrich, R Menapace, E Ries, I Polzer - Journal of cataract and refractive surgery, 1997 - cat.inist.fr Purpose: To evaluate the efficacy and complications of intracameral recombinant
tissue plasminogen activator(r-tPA) in the treatment of severe fibrinous
effusion after cataract and combined cataract and glaucoma surgery. ... Cited by 19 - Related articles - BL Direct - All 3 versions
K Rehfeldt, H Höh - Der Ophthalmologe, 1999 - Springer N icht seltentreten nach kombinierten Katarakt-/Glaukomoperationen bzw. nach
filtrierenden Operationen mit postoperativer Hypotonie Fibrinreak- tionen in der
Vorderkammer auf. Eine lokale antiphlogistische Therapie mit ... Cited by 6 - Related articles - All 2 versions
G Wollensak, JH Meyer, KU Löffler, J Funk - Klinische Monatsblätter für Augenheilkunde, 1996 - ncbi.nlm.nih.gov BACKGROUND: In recent years TPA (tissue-plasminogen activator) has been
increasingly and successfully used for the treatment of severe, postoperative
fibrin reaction in the anterior chamber. So far no serious side effects of ... Cited by 9 - Related articles
F Yoshitomi, E Utsumi, M Hayashi, M … - Journal of cataract and refractive surgery, 1991 - ncbi.nlm.nih.gov We studied the quantitative fluctuations of tissue plasminogen activator (t-PA)
activity and antigen in aqueous humor before and after extracapsular cataract
extraction and poly(methyl methacrylate) posterior chamber lens ... Cited by 9 - Related articles - All 2 versions
ML McDermott, HF Edelhauser, RA Hyndiuk, … - American journal of ophthalmology, 1989 - ncbi.nlm.nih.gov 1: Am J Ophthalmol. 1989 Jul 15;108(1):91-2. Tissue plasminogen activator and the
corneal endothelium. McDermott ML, Edelhauser HF, Hyndiuk RA, Koenig SB. ... Cited by 15 - Related articles
A Heiligenhaus, H Schilling, M Schilling, KB … - Der Ophthalmologe: Zeitschrift der Deutschen …, 1996 - ncbi.nlm.nih.gov The postoperative course after cataract surgery can be complicated by the
formation of severe fibrinous membranes, especially in cases with previous
goniotrepanation, after syn echiolysis, iridotomy or iris suturing, and in ... Cited by 4 - Related articles
N Erol, A Ozer, S Topbas, N Yildirim, S … - Ophthalmic surgery, lasers & imaging: the official … - ncbi.nlm.nih.gov BACKGROUND AND OBJECTIVE: To evaluate the efficacy of intracameral tissue
plasminogen activator (tPA) in the treatment of severe fibrinous membranes that
do not respond to anti-inflammatory treatment. PATIENTS AND METHODS: In ... Cited by 10 - Related articles - BL Direct - All 4 versions
